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The long-chain PUFA (LCPUFA) content of an infant’s diet might affect early weight gain. In early trials on supplementation of formula feeding
n-3 LCPUFA affected weight gain adversely. n-6 LCPUFA are thought to promote adipose tissue development and might be associated with higher
weight gain. We studied the association between the natural n-3 and n-6 LCPUFA content of breast milk of Dutch women and weight and BMI
gain of their breast-fed infants in the first year of life. The children in this study were enrolled in the Prevention and Incidence of Asthma and Mite
Allergy (PIAMA) birth cohort study and were born in 1996–1997 in the Netherlands. Parents reported their child’s weight and length in a ques-
tionnaire. Of a subgroup of the total population breast-milk samples were collected (n 244). The fatty acid composition of breast milk was deter-
mined by GLC and expressed as weight percentages. Linear regression was used for data analysis. Mean gain in weight, length and BMI per week
from birth to 1 year of age was 119·5 (SD 16·1) g, 0·48 (SD 0·05) cm and 0·06 (SD 0·03) kg/m2, respectively. The associations between n-6 and n-3
LCPUFA in breast milk, and infant weight, length and BMI gain were weak and inconsistent. The n-3 and n-6 LCPUFA content in breast milk did
not affect weight or BMI gain in the first year of life in breast-fed term infants.
Breast milk: Infant growth: Long-chain PUFA: Weight gain: BMI
The long-chain PUFA (LCPUFA, derivatives of linoleic acid
(18 : 2n-6; LA) and a-linolenic acid (18 : 3n-3; ALA)) content
of an infant’s diet might affect early growth. In particular the
ratio between n-6 and n-3 LCPUFA could play a role. Early
trials on supplementation of formula feeding showed that for-
mula supplemented with n-3 LCPUFA affected infant growth
adversely(1,2). However, Makrides et al. (3) concluded in a
meta-analysis that supplementation of infant formula with
n-3 LCPUFA (with or without n-6 LCPUFA) did not influence
growth of term-infants, which was in accordance with two
reviews(4,5). Evidence from experimental and animal studies
suggests that arachidonic acid (20 : 4n-6; AA), the main
LCPUFA of the n-6 family, is a potent adipogenic factor
that promotes adipose tissue development and possibly obesity,
while n-3 LCPUFA could reduce an excessive increase
in adipose tissue(6 – 8). Furthermore, in obese subjects, a
higher n-6 LCPUFA serum level(9,10) and a lower n-3
LCPUFA level(11) compared with normal-weight subjects has
been reported.
During early development, the newborn infant is largely
dependent on dietary intake for his or her n-6 and n-3
LCPUFA supply. The infant is capable of conversion of LA
and ALA to their long-chain derivatives, but the enzymatic
systems involved seem to be unable to supply sufficient
LCPUFA to meet the requirements(12,13). Breast-fed infants
rely on the LCPUFA present in the breast milk. In general,
the fatty acid composition of breast milk reflects the long-term
dietary intake of fatty acids by the mother(14 – 16). However,
the current diet may also influence the fatty acid composition
of the breast milk(17). A close relationship has been observed
between the breast-milk fatty acid composition and infant
plasma and tissue fatty acids levels(18 – 20).
We hypothesized that high n-6 LCPUFA content in
breast milk is associated with higher infant weight and
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BMI gain from birth to 1 year of age, while high n-3
LCPUFA content is associated with lower infant weight
and BMI gain.
Methods
Study design and study population
The study population consisted of 244 mothers and children
enrolled in the Prevention and Incidence of Asthma and
Mite Allergy (PIAMA) birth cohort study. The children
were born in 1996–1997 in the Netherlands. A detailed
description of the study design has previously been
published(21). At baseline, the study population consisted of
children of 4146 mothers who were recruited from the general
population during pregnancy. Data were mainly collected by
means of questionnaires that contained questions on weight
and length of the child, breast-feeding duration, and other
maternal and child characteristics. In addition, a subsample
of the study population (n 1990) was selected for house
visits. When the child was about 3 months of age, 1860
families agreed to participate and were visited at home.
At that time, 661 of the mothers visited at home were still
breast-feeding, and 276 of them were willing and able to pro-
duce a milk sample. Two children were lost to follow-up at
1 year of age. Children who were born prematurely (n 2)
and children of mothers who donated a milk sample when
the child was younger than 6 weeks or older than 26 weeks
of age (n 7) were excluded from analysis. One observation
was excluded due to extreme values for n-3 LCPUFA (more
than nine times the standard deviation). Data on birth
weight, weight at 1 year of age and length at 1 year of age
were not available for twenty children, leaving 244 children
available for analysis. Birth length was available for 177
children, as length at birth is often not measured in the
Netherlands. Subsequently, weight gain per week from birth
to 1 year of age could be calculated for 244 children, and
length gain per week and BMI gain per week could be
calculated for 177 children. The study protocol was approved
by the medical ethics committees of the participating insti-
tutes. All parents gave written informed consent.
Assessment of fatty acid composition of breast milk
Breast-milk samples were collected either by manual
expression or by breast pump, depending on the preference
of the mother. The samples were put into tubes containing
2 ml butylated hydroxyl toluene solution (500 mg/ml) to pre-
vent oxidation. They were sent by mail to the National Insti-
tute of Public Health and the Environment and stored there
at 2 708C. Fatty acid composition of the breast milk was
determined by GLC, as described by Foreman- van Drongelen
et al. (22). Details of breast-milk collection and analysis have
been reported elsewhere(23,24). In total, thirty-four individual
fatty acids were measured as weight percentage of the total
fat content (wt%). Total n-6 LCPUFA, total n-3 LCPUFA,
n-3:n-6 LCPUFA ratio, AA, EPA and DHA were the exposure
variables of main interest. In addition, total n-6 PUFA, total
n-3 PUFA, n-3:n-6 PUFA ratio, LA, and ALA were included
as exposure variables.
Outcome and confounder assessment
In the questionnaire sent to the parents when the child was
about 1 year of age the parents reported weight and length
of the child the last time the child was measured. Gender,
gestational age, breast-feeding duration (in weeks), maternal
smoking during pregnancy (any smoking by the mother
during pregnancy from 4 weeks of pregnancy), birth weight,
and birth length were also reported by the parents. BMI was
calculated as weight (kg) divided by length (m) squared.
Since age of the child at reported weight and length ranged
from 9 to 15 months, weight and length of the individual
infants were standardized to exactly 12 months, using the
average increase in weight and length per week. Weight gain,
length gain and BMI gain were defined as the difference
in weight, length, and BMI between birth and 1 year of age.
Weight gain, length gain, and BMI gain were expressed as g,
cm and kg/m2 per week, respectively. A high BMI gain per
week in the first year of life was defined as a BMI gain above
one standard deviation of the mean. Maternal pre-pregnancy
BMI (kg/m2) was calculated from self-reported body weight
(kg) and height (m).
Maternal habitual fish-intake during lactation was reported
in the questionnaire administered to the parents when the
child was 3 month of age. At the breast-milk collection the
mothers filled in a short questionnaire and reported how
often they had consumed fish in the previous week.
Statistical analyses
The individual fatty acids and groups of fatty acids were
divided in tertiles and the intermediate tertile was used as
reference, because we expected that the associations between
the fatty acids and infant weight, length, and BMI gain were
not linear. We analyzed the data using linear and logistic
regression. Different fatty acids were not included simul-
taneously in the regression models due to high correlation
between fatty acids. The association between maternal pre-
pregnancy BMI and the fatty acid composition of breast
milk was analyzed using polytomous logistic regression,
with maternal pre-pregnancy BMI as exposure variable.
The following variables were considered as potential con-
founders: gender, age of the child at weight measurement, age
of the child at breast-milk donation, method of breast-milk
collection (before or between feeds), time of the day of
breast-milk collection, maternal pre-pregnancy BMI, maternal
smoking during pregnancy, and total breast-feeding duration.
A variable was considered a confounder if inclusion of this
variable in the regression model changed the association
between total n-6 PUFA, total n-3 PUFA, total n-6 LCPUFA,
or total n-3 LCPUFA and BMI gain by 10 % or more. Age of
the child at breast-milk donation and total breast-feeding
duration were confounding variables, and thus included in the
adjusted regression models.
The regression analyses were repeated for infants who were
breast-fed for over 6 months and with inclusion of the child
who was excluded due to an extreme value for n-3 LCPUFA.
Furthermore, the observations included in the analyses were
compared with the excluded observations. Data analysis was
conducted using SAS software version 9.1 (SAS Institute,
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Inc., Cary, NC, USA). P values ,0·05 were considered to be
statistically significant.
Results
The study population comprised 48 % girls (n 117). In Table 1
birth weight, weight, length and BMI at 1 year and gain in
weight, length and BMI in the first year of life are presented.
Twenty-six children (10·7 %) had a birth weight below 3000 g
of whom three children had a birth weight below 2500 g. Age
of the child at breast-milk donation was 15·1 (SD 3·4) weeks
and ranged from 9 to 26 weeks (Table 1). In Table 2 the
proportions (wt%) of the various fatty acids in breast milk
are shown.
The mothers who donated a breast-milk sample and who
were included in the present study were, on average, more
often highly educated, smoked less often during pregnancy
and breast-fed longer than the breast-feeding mothers who
did not. No differences were observed in gender, birth
weight, and birth length of the infant.
Table 3 shows the adjusted associations between the fatty
acids in breast milk and weight, length, and BMI gain per
week from birth to 1 year of age. The majority of the associ-
ations were weak, were not statistically significant, and did not
follow a dose–response relationship. Both low and high total
n-6 LCPUFA content in breast milk were inversely associated
with weight gain and BMI gain from birth to 1 year of age
compared with intermediate total n-6 LCPUFA content, but
the associations were not statistically significant. Low and
high AA content was associated with lower weight gain and
was significantly associated with lower BMI gain compared
to intermediate AA content. Children fed breast-milk high in
AA had, on average, a 4·6 g lower weight gain per week in
the first year of life. Total n-6 PUFA showed a significant
association with weight gain and BMI gain. Low and high
total n-6 PUFA content was associated with lower weight
gain and with lower BMI gain compared with intermediate
n-6 PUFA content. No significant associations were observed
between total n-3 LCPUFA, EPA or DHA, and weight gain,
length gain and BMI gain. When high BMI gain per week
in the first year of life compared with normal BMI gain was
studied as an outcome variable instead of BMI gain as a
continuous variable, the results were similar to the results
described earlier. Adjustment for age of the infant at breast-
milk collection and total breast-feeding duration did not
affect the results to a large extent and did not lead to a differ-
ent conclusion. The results of the analyses did not differ when
the analyses were restricted to infants who were breast-fed for
at least 6 months (n 140).
Maternal pre-pregnancy BMI was not significantly associ-
ated with any of the fatty acids in breast milk (data not shown).
The maternal fish-intake in the week previous to the breast
milk collection corresponded to the habitual fish-intake during
lactation. Fish consumption during lactation was significantly
associated with the n-3 LCPUFA, EPA and DHA content of
the breast milk but not with weight, length and BMI gain in
the children (data not shown).
Discussion
We did not find evidence supporting the hypothesis that n-6
LCPUFA increased infant weight and BMI gain. Both high
and low levels of AA, and of the precursor of AA, LA,
were associated with a lower infant weight gain and BMI
gain compared with an intermediate level. n-3 LCPUFA did
not affect infant weight, length and BMI gain adversely in
our analyses.
To our knowledge, this study is one of the first observa-
tional studies that investigates the association between the
natural fatty acid composition of breast milk and infant
weight, length and BMI gain. The fatty acid composition of
the breast milk and the levels of n-6 and n-3 LCPUFA corre-
sponded with data from other Dutch studies and is typical for
women consuming a western diet(12,14,25,26).
The number of subjects included in the study was thought to
be adequate to detect an association, because the number of
children that participated in this study was larger than in
most intervention studies on the intake of LCPUFA and
infant growth. Also, in an earlier study by Wijga et al. a sig-
nificant association was observed between breast-milk n-3
LCPUFA and eczema and asthma symptoms in children
using the same data(27).
A limitation of the present study was that only one breast-
milk sample was collected. Although the breast-milk fatty acid
composition reflects the long-term intake by the mother(14 – 16),
the current diet may influence the fatty acid composition of the
Table 1. Study characteristics (n 244)
(Mean values and standard deviations)
Variable n Mean SD
Birth weight (g) 244 3555 491
Birth length (cm) 177 51·3 2·3
BMI at birth (kg/m2) 177 13·6 1·4
Weight at 1 year (g) 244 9788 993
Length at 1 year (cm) 244 76·2 2·8
BMI at 1 year (kg/m2) 244 16·9 1·3
Weight gain (g/week) 244 119·5 16·1
Length gain (cm/week) 177 0·48 0·05
BMI gain (kg/m2 per week) 177 0·06 0·03
Age of infant at breast-milk
donation (weeks)
244 15·1 3·4
Total breast-feeding duration (weeks) 244 29·9 12·8
Table 2. Fatty acid content (wt%) of breast milk in Dutch mothers
(n 244)
(Mean values and standard deviations)
Fatty acids (wt%) Mean SD
Total n-6 PUFA 16·197 4·197
Total n-3 PUFA 1·530 0·429
Total n-6 LCPUFA 1·126 0·276
Total n-3 LCPUFA 0·514 0·210
n-3:n-6 PUFA 0·099 0·031
n-3:n-6 LCPUFA 0·471 0·197
Linoleic acid (18 : 2n-6) 15·070 4·089
a-Linolenic acid (18 : 3n-3) 1·016 0·375
Arachidonic acid (20 : 4n-6) 0·370 0·092
EPA (20 : 5n-3) 0·050 0·042
DHA (22 : 6n-3) 0·195 0·128
LCPUFA, long-chain PUFA.
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breast-milk also(17). Since we collected only one breast-milk
sample we cannot be certain that the fatty acid composition
in the breast-milk sample reflects the fatty acid composition
of the breast milk of the entire lactation period. However,
we did not expect that the maternal diet during lactation chan-
ged to an extent that it would influence the results of this
study. For instance, the maternal fish-consumption in the
week previous to the breast-milk collection corresponded
with habitual fish intake.
It is not likely that the infant’s fatty acid intake via other
foods than breast milk influenced the association between
fatty acid intake by breast milk and weight gain, since the
infants were breast-fed for 30 weeks on average and other
foods make up only a small part of the diet in infancy.
Besides, even if the infants received some LCPUFA via
foods, all children did and probably in similar quantities.
Therefore, it is unlikely that LCPUFA from another source
than breast milk would have distorted the association between
the fatty acid composition of the breast milk and infant
weight gain.
Another limitation was that the breast-milk samples were
not collected at the same age of the infant. However, the
fatty acids composition differed only slightly with age of
the child at breast-milk collection and we included age of
the child at collection as a confounder in our analyses.
Furthermore, the mothers were free to choose when to collect
the sample (before, during or after the feeding) and at which
time of the day. Analyses of the method and time of collection
of the breast milk showed no differences in fatty acids content.
Another limitation was that age of the child at weight and
length measurement differed between children. We tried to
overcome this problem by standardizing weight, length and
BMI to 12 months of age. Although, weight and length of
the child were reported by the parents, it is not likely that
this caused bias. In the Netherlands, infants are weighed and
measured regularly in the first year of life in under-five-clinics
and parents receive a booklet recording weight and length of
their child. It is unlikely that parents underreported or over-
reported weight or length of their child at such a young age.
Parental reported pre-pregnancy weight of the mother, on the
other hand, could be underestimated. Since this underestima-
tion is probably not associated with the fatty acid composition
of the breast milk, it is unlikely that it has influenced the
direction of our results, though it might have weakened our
associations. Since only mothers who were still breast-feeding
during the house visit were eligible for this study, some selec-
tion bias might have occurred. For instance, the mothers in this
sample were higher educated than the total study population.
However, we do not have reason to expect that the observed
associations are different in the total population.
The results of our study correspond with the conclusions of
meta-analyses on the effect of supplementation of formula
feeding with LCPUFA on weight and length gain in term
infants(3 – 5). They reported no association between n-3 and
n-6 LCPUFA and weight and length gain in term infants.
Also, a study that investigated the association between eryth-
rocyte LCPUFA levels in French and Mauritian infants and
anthropometric parameters observed no difference in weight
and length at 6 weeks of age(19). Weight and length of infants
of mothers receiving a supplement rich in n-3 LCPUFA during
lactation, which did increase the n-3 LCPUFA content in
the mothers’ breast milk, did not differ in the first year
of life(28,29). Lauritzen et al. (28), observed a higher BMI at
2·5 years of age in the children of Danish mothers who had
Table 3. Adjusted associations* between tertiles of fatty acids (intermediate tertile is reference) in breast milk and weight gain (n 244), length gain and
BMI gain (n 177) in breast-fed infants per week from birth to 1 year of age
Weight gain (g/week) Length gain (cm/week) BMI gain (kg/m2 per week)
Fatty acids Tertile b 95 % CI b 95 % CI b 95 % CI
Total n-6 PUFA Low 25·564† 210·496, 20·631 20·012 20·030, 0·005 20·008 20·020, 0·003
High 25·579† 210·470, 20·688 0·005 20·012, 0·023 20·014† 20·025, 20·002
Total n-3 PUFA Low 20·253 25·216, 4·710 20·004 20·022, 0·014 20·001 20·013, 0·011
High 2·843 22·170, 7·856 20·002 20·020, 0·015 0·008 20·004, 0·019
Total n-6 LCPUFA Low 22·077 27·022, 2·867 20·013 20·031, 0·005 20·005 20·017, 0·007
High 23·001 28·010, 2·008 0·004 20·014, 0·022 20·008 20·019, 0·004
Total n-3 LCPUFA Low 20·329 25·282, 4·624 0·009 20·008, 0·027 20·009 20·021, 0·003
High 21·574 26·532, 3·383 0·016 20·001, 0·033 20·010 20·021, 0·001
n-3:n-6 PUFA Low 20·397 25·476, 4·682 0·009 20·009, 0·027 20·004 20·016, 0·008
High 2·388 22·725, 7·501 0·001 20·017, 0·019 0·005 20·007, 0·017
n-3:n-6 LCPUFA Low 23·045 28·019, 1·929 0·009 20·009, 0·027 20·009 20·021, 0·003
High 22·735 27·676, 2·206 0·004 20·014, 0·022 20·007 20·019, 0·004
LA (18 : 2n-6) Low 25·317† 210·234, 20·401 20·009 20·027, 0·008 20·006 20·018, 0·005
High 25·132† 210·037, 20·227 0·007 20·010, 0·025 20·013† 20·025, 20·002
ALA (18 : 3n-3) Low 21·640 26·596, 3·316 20·010 20·028, 0·008 0·002 20·010, 0·014
High 0·697 24·275, 5·669 20·011 20·029, 0·007 0·007 20·004, 0·019
AA (20 : 4n-6) Low 23·877 28·810, 1·055 20·005 20·023, 0·013 20·012† 20·024, 20·001
High 24·550 29·474, 0·373 0·010 20·008, 0·027 20·017† 20·028, 20·005
EPA (20 : 5n-3) Low 3·187 21·776, 8·151 0·010 20·008, 0·028 20·003 20·015, 0·009
High 2·434 22·516, 7·384 0·007 20·011, 0·025 20·004 20·015, 0·008
DHA (22 : 6n-3) Low 0·606 24·387, 5·599 20·013 20·031, 0·005 0·009 20·003, 0·020
High 0·833 24·124, 5·789 20·006 20·024, 0·012 0·004 20·008, 0·016
LA, linoleic acid; ALA, a-linolenic acid; AA, arachidonic acid.
* Regression models contain the exposure variables (low and high fatty acid tertiles), age of child at breast-milk collection and total breast-feeding duration.
†P,0·05.
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received n-3 LCPUFA supplementation during lactation.
However, a German study showed a lower BMI at 21 months
in children of mothers supplemented with DHA during
lactation(30). Since the association between n-3 LCPUFA and
BMI gain was very small in our observational study, we do
not expect that a longer follow-up would reveal a positive
association between n-3 LCPUFA and BMI. A study in Chinese
infants living in a rural area reported a positive association
between AA in breast milk and weight gain in the first
3 months of life and a positive association between AA and
DHA in breast milk and length gain in the first 3 months
of life(31). This study included a small study sample
(twenty-three infants at 3 months) and the breast milk n-6
PUFA content was considerably higher than in our study.
An inverse association was observed between a high breast
milk n-6 LCPUFA content, and infant weight and BMI gain.
n-6 LCPUFA derive from n-6 PUFA, in particular LA. n-6
PUFA were also associated with a lower weight and BMI
gain. The reason for the lower weight gain in infants fed
breast-milk containing a high n-6 LCPUFA or n-6 PUFA con-
tent remains unclear. The fatty acid composition of breast milk
reflects the long-term dietary intake of fatty acids by the
mother(14 – 16). Mothers whose breast milk is high in n-6
LCPUFA and n-6 PUFA, most likely have a diet that is
high in n-6 PUFA. Possibly other nutrients associated with
the consumption of a diet high in n-6 PUFA might influence
infant weight and BMI gain.
In conclusion, we did not observe a consistent association
between n-3 and n-6 LCPUFA in breast milk and weight
and BMI gain in the first year of life in breast-fed term infants.
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